======= TAOK1 =======
== Gene Information ==
* **Official Symbol**: TAOK1
* **Official Name**: TAO kinase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57551|57551]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q7L7X3|Q7L7X3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TAOK1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAOK1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610266|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. {ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936}.
|Pkinase Tyr|
|Pkinase|
|mitotic G2 DNA damage checkpoint|
|MAP kinase kinase kinase activity|
|tau-protein kinase activity|
|negative regulation of microtubule depolymerization|
|mitotic G2/M transition checkpoint|
|regulation of microtubule depolymerization|
|protein serine/threonine kinase activator activity|
|G2 DNA damage checkpoint|
|neuron cellular homeostasis|
|negative regulation of microtubule polymerization or depolymerization|
|beta-tubulin binding|
|alpha-tubulin binding|
|activation of JUN kinase activity|
|positive regulation of protein acetylation|
|tau protein binding|
|activation of MAPKK activity|
|execution phase of apoptosis|
|transferase activity|
|negative regulation of protein depolymerization|
|negative regulation of protein complex disassembly|
|regulation of protein acetylation|
|positive regulation of JUN kinase activity|
|kinase activity|
|regulation of microtubule polymerization or depolymerization|
|JNK cascade|
|regulation of protein depolymerization|
|regulation of JUN kinase activity|
|negative regulation of G2/M transition of mitotic cell cycle|
|mitotic DNA damage checkpoint|
|negative regulation of cell cycle G2/M phase transition|
|mitotic DNA integrity checkpoint|
|stress-activated MAPK cascade|
|regulation of protein complex disassembly|
|negative regulation of supramolecular fiber organization|
|DNA damage checkpoint|
|positive regulation of JNK cascade|
|negative regulation of cytoskeleton organization|
|stress-activated protein kinase signaling cascade|
|DNA integrity checkpoint|
|microtubule cytoskeleton|
|mitotic cell cycle checkpoint|
|activation of MAPK activity|
|positive regulation of stress-activated MAPK cascade|
|positive regulation of stress-activated protein kinase signaling cascade|
|regulation of JNK cascade|
|regulation of microtubule cytoskeleton organization|
|protein autophosphorylation|
|cell cycle checkpoint|
|regulation of G2/M transition of mitotic cell cycle|
|regulation of cell cycle G2/M phase transition|
|negative regulation of mitotic cell cycle phase transition|
|regulation of microtubule-based process|
|negative regulation of cell cycle phase transition|
|regulation of stress-activated MAPK cascade|
|regulation of stress-activated protein kinase signaling cascade|
|protein kinase activity|
|positive regulation of MAP kinase activity|
|negative regulation of mitotic cell cycle|
|negative regulation of cell cycle process|
|activation of protein kinase activity|
|positive regulation of protein serine/threonine kinase activity|
|anatomical structure homeostasis|
|regulation of MAP kinase activity|
|regulation of actin cytoskeleton organization|
|regulation of supramolecular fiber organization|
|protein serine/threonine kinase activity|
|MAPK cascade|
|negative regulation of organelle organization|
|regulation of actin filament-based process|
|signal transduction by protein phosphorylation|
|regulation of mitotic cell cycle phase transition|
|regulation of cell cycle phase transition|
|microtubule cytoskeleton organization|
|DNA repair|
|regulation of protein serine/threonine kinase activity|
|positive regulation of protein kinase activity|
|regulation of cytoskeleton organization|
|positive regulation of MAPK cascade|
|negative regulation of cell cycle|
|positive regulation of kinase activity|
|mitotic cell cycle process|
|regulation of mitotic cell cycle|
|positive regulation of transferase activity|
|microtubule-based process|
|mitotic cell cycle|
|perinuclear region of cytoplasm|
|negative regulation of cellular component organization|
|regulation of cellular response to stress|
|DNA metabolic process|
|regulation of cell cycle process|
|regulation of MAPK cascade|
|cellular response to DNA damage stimulus|
|regulation of protein kinase activity|
|regulation of kinase activity|
|cellular homeostasis|
|apoptotic process|
|protein phosphorylation|
|regulation of transferase activity|
|cell cycle process|
|positive regulation of protein phosphorylation|
|positive regulation of intracellular signal transduction|
|programmed cell death|
|positive regulation of phosphorylation|
|cell death|
|cytoskeleton organization|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|regulation of cell cycle|
|positive regulation of protein modification process|
|phosphorylation|
|regulation of organelle organization|
|cell cycle|
|positive regulation of catalytic activity|
|regulation of protein phosphorylation|
|regulation of response to stress|
|ATP binding|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|homeostatic process|
|positive regulation of signal transduction|
|intracellular signal transduction|
|cellular response to stress|
|positive regulation of protein metabolic process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16773
* **Expression level (log2 read counts)**: 7.46
{{:chemogenomics:nalm6 dist.png?nolink |}}